Total Liabilities Summary of Novartis AG

Novartis AG's latest annual total liabilities in 2023 was 53.19 Billion USD , down -8.33% from previous year.
Novartis AG's latest quarterly total liabilities in 2024 Q3 was 60.08 Billion USD , up 8.06% from previous quarter.
Novartis AG reported annual total liabilities of 58.03 Billion USD in 2022, down -9.29% from previous year.
Novartis AG reported annual total liabilities of 63.97 Billion USD in 2021, down -15.15% from previous year.
Novartis AG reported quarterly total liabilities of 60.08 Billion USD for 2024 Q3, up 8.06% from previous quarter.
Novartis AG reported quarterly total liabilities of 54.57 Billion USD for 2024 Q1, up 2.6% from previous quarter.

Annual Total Liabilities Chart of Novartis AG (2023 - 1998)

Historical Annual Total Liabilities of Novartis AG (2023 - 1998)

Year	Total Liabilities	Total Liabilities Growth
2023	53.19 Billion USD	-8.33%
2022	58.03 Billion USD	-9.29%
2021	63.97 Billion USD	-15.15%
2020	75.39 Billion USD	20.02%
2019	62.81 Billion USD	-6.06%
2018	66.87 Billion USD	13.63%
2017	58.85 Billion USD	6.55%
2016	55.23 Billion USD	1.47%
2015	54.43 Billion USD	-0.2%
2014	54.54 Billion USD	5.33%
2013	51.78 Billion USD	-5.85%
2012	54.99 Billion USD	6.67%
2011	51.55 Billion USD	-3.72%
2010	53.54 Billion USD	40.76%
2009	38.04 Billion USD	36.54%
2008	27.86 Billion USD	6.93%
2007	26.05 Billion USD	-2.46%
2006	26.71 Billion USD	8.73%
2005	24.56 Billion USD	19.56%
2004	20.54 Billion USD	9.31%
2003	18.79 Billion USD	12.33%
2002	16.73 Billion USD	13.47%
2001	14.74 Billion USD	13.79%
2000	12.96 Billion USD	-26.64%
1999	17.66 Billion USD	0.63%
1998	17.55 Billion USD	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	55.6 Billion USD	1.88%
2024 Q3	60.08 Billion USD	8.06%
2024 Q1	54.57 Billion USD	2.6%
2023 FY	53.19 Billion USD	-8.33%
2023 Q4	53.19 Billion USD	-28.55%
2023 Q2	59.04 Billion USD	-1.75%
2023 Q1	60.09 Billion USD	3.57%
2023 Q3	74.45 Billion USD	26.09%
2022 Q3	57.56 Billion USD	-3.9%
2022 FY	58.03 Billion USD	-9.29%
2022 Q4	58.03 Billion USD	0.81%
2022 Q2	59.9 Billion USD	-5.68%
2022 Q1	63.51 Billion USD	-0.72%
2021 Q1	71.16 Billion USD	-5.61%
2021 FY	63.97 Billion USD	-15.15%
2021 Q4	63.97 Billion USD	-0.47%
2021 Q3	64.27 Billion USD	-8.03%
2021 Q2	69.88 Billion USD	-1.79%
2020 Q2	69.87 Billion USD	-3.11%
2020 Q1	72.12 Billion USD	14.81%
2020 Q3	75.12 Billion USD	7.51%
2020 Q4	75.39 Billion USD	0.36%
2020 FY	75.39 Billion USD	20.02%
2019 Q1	90.63 Billion USD	35.54%
2019 FY	62.81 Billion USD	-6.06%
2019 Q3	63.37 Billion USD	-2.19%
2019 Q4	62.81 Billion USD	-0.87%
2019 Q2	64.79 Billion USD	-28.52%
2018 Q1	64.31 Billion USD	9.28%
2018 FY	66.87 Billion USD	13.63%
2018 Q4	66.87 Billion USD	2.92%
2018 Q3	64.97 Billion USD	-0.28%
2018 Q2	65.15 Billion USD	1.31%
2017 Q3	62.6 Billion USD	-1.83%
2017 Q4	58.85 Billion USD	-5.99%
2017 FY	58.85 Billion USD	6.55%
2017 Q1	64.34 Billion USD	16.49%
2017 Q2	63.77 Billion USD	-0.88%
2016 Q1	60.55 Billion USD	11.25%
2016 FY	55.23 Billion USD	1.47%
2016 Q2	58.9 Billion USD	-2.73%
2016 Q3	58.94 Billion USD	0.06%
2016 Q4	55.23 Billion USD	-6.29%
2015 Q2	56.58 Billion USD	-3.27%
2015 Q3	56.14 Billion USD	-0.78%
2015 Q1	58.49 Billion USD	7.24%
2015 FY	54.43 Billion USD	-0.2%
2015 Q4	54.43 Billion USD	-3.04%
2014 Q3	53.95 Billion USD	-2.35%
2014 Q1	54.99 Billion USD	6.21%
2014 FY	54.54 Billion USD	5.33%
2014 Q4	54.54 Billion USD	1.09%
2014 Q2	55.25 Billion USD	0.46%
2013 Q1	53.86 Billion USD	-2.06%
2013 Q2	51.44 Billion USD	-4.49%
2013 FY	51.78 Billion USD	-5.85%
2013 Q3	52.41 Billion USD	1.89%
2013 Q4	51.78 Billion USD	-1.21%
2012 Q1	56.21 Billion USD	9.03%
2012 Q2	54.25 Billion USD	-3.49%
2012 Q3	54.01 Billion USD	-0.44%
2012 Q4	54.99 Billion USD	1.82%
2012 FY	54.99 Billion USD	6.67%
2011 Q3	55.23 Billion USD	-6.1%
2011 FY	51.55 Billion USD	-3.72%
2011 Q4	51.55 Billion USD	-6.66%
2011 Q2	58.82 Billion USD	-4.94%
2011 Q1	61.87 Billion USD	15.55%
2010 Q3	58.41 Billion USD	42.09%
2010 Q2	41.1 Billion USD	1.3%
2010 FY	53.54 Billion USD	40.76%
2010 Q4	53.54 Billion USD	-8.32%
2010 Q1	40.57 Billion USD	6.67%
2009 Q3	37.37 Billion USD	10.62%
2009 Q4	38.04 Billion USD	1.79%
2009 FY	38.04 Billion USD	36.54%
2009 Q2	33.78 Billion USD	6.44%
2009 Q1	31.74 Billion USD	13.93%
2008 Q1	27.05 Billion USD	3.82%
2008 Q3	31.28 Billion USD	-1.61%
2008 Q4	27.86 Billion USD	-10.94%
2008 FY	27.86 Billion USD	6.93%
2008 Q2	31.79 Billion USD	17.53%
2007 Q1	27.82 Billion USD	4.15%
2007 Q2	26.95 Billion USD	-3.11%
2007 FY	26.05 Billion USD	-2.46%
2007 Q4	26.05 Billion USD	-5.05%
2007 Q3	27.44 Billion USD	1.8%
2006 Q3	28.27 Billion USD	-1.71%
2006 Q2	28.76 Billion USD	14.63%
2006 Q1	25.09 Billion USD	2.14%
2006 FY	26.71 Billion USD	8.73%
2006 Q4	26.71 Billion USD	-5.51%
2005 Q1	20.18 Billion USD	-1.77%
2005 Q4	24.56 Billion USD	7.13%
2005 Q2	22.65 Billion USD	12.22%
2005 Q3	22.93 Billion USD	1.25%
2005 FY	24.56 Billion USD	19.56%
2004 Q4	20.54 Billion USD	11.61%
2004 Q1	18.94 Billion USD	0.77%
2004 Q2	18.39 Billion USD	-2.91%
2004 FY	20.54 Billion USD	9.31%
2004 Q3	18.41 Billion USD	0.1%
2003 Q3	17.88 Billion USD	-6.93%
2003 Q2	19.21 Billion USD	3.05%
2003 Q4	18.79 Billion USD	5.09%
2003 FY	18.79 Billion USD	12.33%
2003 Q1	18.64 Billion USD	11.44%
2002 Q2	15.13 Billion USD	0.0%
2002 FY	16.73 Billion USD	13.47%
2002 Q4	16.73 Billion USD	9.74%
2002 Q3	15.24 Billion USD	0.73%
2001 Q2	13.91 Billion USD	0.0%
2001 FY	14.74 Billion USD	13.79%
2001 Q4	14.74 Billion USD	0.0%
2000 Q4	12.96 Billion USD	0.0%
2000 FY	12.96 Billion USD	-26.64%
2000 Q2	15.57 Billion USD	0.0%
1999 FY	17.66 Billion USD	0.63%
1998 FY	17.55 Billion USD	0.0%

Peer Total Liabilities Comparison of Novartis AG

Name	Total Liabilities	Total Liabilities Difference
AbbVie Inc.	124.31 Billion USD	57.209%
Bristol-Myers Squibb Company	65.67 Billion USD	19.001%
Bristol-Myers Squibb Company Ce	65.67 Billion USD	19.001%
Johnson & Johnson	98.78 Billion USD	46.15%
Eli Lilly and Company	53.14 Billion USD	-0.099%
Merck & Co., Inc.	69.04 Billion USD	22.95%
Organon & Co.	12.12 Billion USD	-338.613%
Pfizer Inc.	137.21 Billion USD	61.232%

Global Stocks Search

Novartis AG (NVS)

Total Liabilities Summary of Novartis AG

Annual Total Liabilities Chart of Novartis AG (2023 - 1998)

Historical Annual Total Liabilities of Novartis AG (2023 - 1998)

Peer Total Liabilities Comparison of Novartis AG